Bausch Health Reports Strong Q2 Growth, Raises Guidance
Company Announcements

Bausch Health Reports Strong Q2 Growth, Raises Guidance

Story Highlights

Bausch Health Companies (TSE:BHC) has released an update.

Bausch Health Companies Inc. has reported a robust second quarter in 2024 with consolidated revenues increasing by 11% to $2.40 billion, and an organic growth of 8%. The company also saw a rise in adjusted EBITDA by 10% and has raised its full-year revenue and adjusted EBITDA guidance, indicating strong financial health and growth.

For further insights into TSE:BHC stock, check out TipRanks’ Stock Analysis page.

Related Articles
Casey Dylan, CIMABausch + Lomb (BLCO) Posts Impressive Revenue and Explores Potential Sale
TipRanks Auto-Generated NewsdeskBausch Health Reports Growth Amid Improved Financials
TipRanks Canadian Auto-Generated NewsdeskBausch Health Reports Strong Growth in Q3 2024
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App